insights_auto
Why is GNPX down 2.34%?
Dive Deeperchevron_right
GNPX:NASDAQ
Genprex Inc
US$1.67
arrow_downward
-2.34%(-0.040) 1D
ኖቬም 19, 4:00:01 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GNPX...
Open
US$1.72
High
US$1.80
Low
US$1.63
Mkt. cap
2.23 ሚ
Avg. vol.
168.28 ሺ
Volume
63.52 ሺ
52-wk high
US$85.14
52-wk low
US$1.63
EPS
-US$172.99
Beta
-0.95
Shares outstanding
1.34 ሚ
No. of employees
13
Open
US$1.72
High
US$1.80
Low
US$1.63
Mkt. cap
2.23 ሚ
Avg. vol.
168.28 ሺ
Volume
63.52 ሺ
52-wk high
US$85.14
52-wk low
US$1.63
EPS
-US$172.99
Beta
-0.95
Shares outstanding
1.34 ሚ
No. of employees
13
News stories
From web sources and news partners
GuruFocus
·
ከ9 ሰዓቶች በፊት
Genprex (GNPX) Identifies Low TROP2 as Biomarker for Resistance to NSCLC Therapy Reqorsa
Investing.com
·
ከ9 ሰዓቶች በፊት
Genprex identifies TROP2 as potential biomarker for lung cancer therapy
About Genprex Inc
CEO-
Employees13
Founded2009
Headquartersኦስቲን, ቴክሳስ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitegenprex.com